BIOBRIEF
On July 8, ten companies, including Anthropic, Microsoft AI, and Amazon One Medical, met privately with the agencies that will regulate and reimburse AI in medicine.
On July 8, inside the FDA's White Oak campus, ten companies sat across from the two federal agencies that will both regulate and reimburse clinical AI. The meeting was closed to the public, to patient advocates, and to independent clinicians, according to STAT, which reviewed the agenda and obtained on-record summaries from four attendees.
The hosts were the FDA and the Centers for Medicare and Medicaid Services. The stated purpose, per STAT: "The meeting was meant to offer federal health officials firsthand experience with AI doctor technology as it exists today." That spans two distinct policy forks: how the FDA treats AI clinicians as medical devices, and how CMS pays for them.
The ten companies in the room, per STAT: Anthropic, Microsoft AI, Amazon One Medical, Counsel Health, Curai, K Health, Doctronic, Ellipsis Health, Hippocratic AI, and Welldoc. The mix is a foundation-model lab (Anthropic), the health arms of two Big Tech firms, and seven venture-backed clinical-AI startups, several backed by Andreessen Horowitz or Khosla Ventures.
STAT confirmed on-record summaries from four: Counsel Health, K Health, Hippocratic AI, and Ellipsis Health. Six of the ten did not speak on the record, so any characterization of their presentations rests on STAT's agenda review.
A closed-door, no-readout meeting, before formal rulemaking has begun, where the industry being regulated is also the one briefing the regulators in person. What the public sees next is whatever those two agencies choose to publish.